Syncromune
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.
1
Funding Rounds
$100.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ea**** Ho*** |
|
- |
Funding series
Funding Series Analysis
The company Syncromune has raised a total of $100m in funding over 1 rounds.
Key Insights:
- Syncromune December 2024 Series A Funding Round: $100m
Syncromune December 2024 Series A Funding Round
$100m
Industries
Syncromune is active in the following industries: